Effects of Muse Cell on a Mouse Model With Acute Encephalopathy
Brain and Behavior · 2025
DOI: 10.1002/brb3.70242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Tatsuya Kawaguchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan. Hauptthemen laut MEDLINE: Brain Diseases, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science kakenhi.
Abstract (Originalsprache)
Introduction
Acute encephalopathy (AE) in childhood due to a viral infection causes convulsions and altered consciousness, leading to severe sequelae and death. Among the four types of AE, cytokine storm–induced AE is the most severe and causes serious damage to the brain. Moreover, a fundamental treatment for AE has not been established yet. Recently, it has been shown that the administration of multilineage‐differentiating stress‐enduring (Muse) cells, a population of mesenchymal stem cells, improves symptoms in various types of brain injuries when administered in the subacute phase (1–7 days after brain damage). We aimed to examine the effects of Muse cells in a cytokine storm–induced AE animal model using immunocompromised nonobese diabetic/severe combined immunodeficiency (NOD/SCID) neonatal mice.
Methods
We established a modified protocol to induce AE‐like symptoms in NOD/SCID. Then, Muse cells were injected at an acute phase (2–4 h after hyperthermia treatment).
Results
Injection of Muse cells significantly improved body weight gain 1 day after treatment and the survival ratio for 3 weeks.
Conclusion
These effects could be a result of the direct and/or indirect upregulation of IL‐10, an anti‐inflammatory cytokine, in the Muse cell–treated brain. Although non‐Muse cells, a residual cell population in the bone marrow after isolating Muse cells, also improved some symptoms, their effects were weaker than those of Muse cells. Our results indicate that the injection of Muse cells in the acute phase has an effect on AE, suggesting that they exert their therapeutic effects not only in the subacute phase but also in the acute phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
- Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan.
- Department of Pediatrics, Nara Medical University Hospital, Kashihara, Japan.
- Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, Yonago, Japan.
- Division of Bacteriology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago, Japan.
ORCID-Profile: Tatsuya Kawaguchi, Tetsuji Mori, Kaori Adachi, Jun Fujii, Yoshihiro Maegaki, Fumiko Obata
Förderung
- Japan Society for the Promotion of Science kakenhi
Zitieren
APA
Kawaguchi, T., Mori, T., Adachi, K., Fujii, J., Maegaki, Y., & Obata, F. (2025). Effects of Muse Cell on a Mouse Model With Acute Encephalopathy. Brain and Behavior. https://doi.org/10.1002/brb3.70242
Vancouver
Kawaguchi T, Mori T, Adachi K, Fujii J, Maegaki Y, Obata F. Effects of Muse Cell on a Mouse Model With Acute Encephalopathy. Brain and Behavior. 2025. doi:10.1002/brb3.70242
BibTeX
@article{Kawaguchi2025,
author = {Kawaguchi, Tatsuya and Mori, Tetsuji and Adachi, Kaori and Fujii, Jun and Maegaki, Yoshihiro and Obata, Fumiko},
title = {Effects of Muse Cell on a Mouse Model With Acute Encephalopathy},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70242}
}
EUVIMED